The medical community is intrigued by retatrutide, a innovative dual GIP and GLP-1 target that’s showing remarkable results in early trials . This medication works by imitating natural hormones to regulate appetite and boost feelings of satiety, ultimately contributing to considerable weight reduction . While presently under review and not yet av